Edgen Stock·Sep 12 2025, 00:33戻る
戻る
Healthcare Giants Navigate Patent Expirations: Strategic Responses of Johnson & Johnson and AbbVie
Edgen Stock·Sep 12 2025, 00:33
[1] J&J vs. AbbVie: Which Healthcare Powerhouse Is Better Positioned? (https://finance.yahoo.com/news/j-j-vs-abbvie- ...)[2] J&J flexes $15B quarter for innovative drugs as biosimilars chip away at Stelara | Fierce Pharma (https://www.fiercepharma.com/pharma/jj-flexes ...)[3] AbbVie (ABBV) Extends Rinvoq's Patent Protection, Boosting Stock - GuruFocus (https://vertexaisearch.cloud.google.com/groun ...)